# Nuclide record nct06504147 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct06504147/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct06504147", "NCT06504147" ;
  schema:name "A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery"@en ;
  schema:description "A phase 2 trial of Radspherin in ovarian cancer, run by Oncoinvent Solutions AS, now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct06504147/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06504147> ;
  nuclide:status "recruiting" ;
  nuclide:tag "pipeline", "ctgov-ingest" ;
  nuclide:phase "2" .